Gifix 200 Tablet DT contains Cefixime 200 mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. Cefixime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, thereby exhibiting bactericidal activity. It is indicated for the treatment of various infections caused by susceptible strains of bacteria, including uncomplicated urinary tract infections, acute otitis media, pharyngitis, tonsillitis, bronchitis, and uncomplicated gonorrhea. The tablet is formulated as a dispersible tablet (DT), allowing for rapid disintegration in the oral cavity without the need for water, enhancing patient compliance, particularly in pediatric and geriatric populations. Gifix 200 should be administered as prescribed, with dosage adjusted based on the severity of infection, patient age, and renal function. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, abdominal pain, and hypersensitivity reactions like rash or pruritus. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Renal function monitoring is recommended during prolonged therapy. Gifix 200 Tablet DT offers an effective therapeutic option for managing bacterial infections, ensuring ease of administration and reliable clinical outcomes when used appropriately under medical supervision.